Kai Feng
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis 13
- Liver Disease and Transplantation 3
- Liver physiology and pathology 2
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 9
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 5
-
- Endoplasmic Reticulum Stress and Disease 4
-
- Gallbladder and Bile Duct Disorders 3
-
- Radiomics and Machine Learning in Medical Imaging 2
In The Last Decade
Kai Feng
21 papers receiving 922 citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Hepatology 665
- Epidemiology 500
- Cancer Research 103
- Surgery 267
- Oncology 136
Countries citing papers authored by Kai Feng
This map shows the geographic impact of Kai Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Feng more than expected).
Fields of papers citing papers by Kai Feng
This network shows the impact of papers produced by Kai Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Feng. The network helps show where Kai Feng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kai Feng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 4 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 5 | |
| 6 | 2022 | 20 | |
| 7 | 2022 | 0 | |
| 8 | 2021 | 0 | |
| 9 | 2020 | 15 | |
| 10 | 2020 | 13 | |
| 11 | 2017 | 12 | |
| 12 | 2016 | 1 | |
| 13 | 2014 | 29 | |
| 14 | 2013 | 35 | |
| 15 | A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinomabreakdown → | 2012 | 551 |
| 16 | 2012 | 6 | |
| 17 | 2012 | 14 | |
| 18 | 2010 | 28 | |
| 19 | 2010 | 19 | |
| 20 | 2006 | 70 |
About Kai Feng
Kai Feng is a scholar working on Hepatology, Epidemiology and Geriatrics and Gerontology, having authored 25 papers that have together received 936 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Liver Disease Diagnosis and Treatment (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Endoplasmic Reticulum Stress and Disease (4 papers), Liver Disease and Transplantation (3 papers), Gallbladder and Bile Duct Disorders (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Liver physiology and pathology (2 papers). The work is most often cited by research in Hepatology (665 citations), Epidemiology (500 citations) and Cancer Research (103 citations). Kai Feng has collaborated with scholars based in China, Sweden and Hong Kong. Frequent co-authors include Kuansheng Ma, Ping Bie, X Y Feng, Shuguang Wang, Xiaowu Li, Jiahong Dong, Jun Yan, Peifen Zhu, Aiqing Wen and Jianxin Jiang. Their work appears in journals such as Journal of Hepatology, British journal of surgery and World Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.